Immunotherapy treatments have revolutionized the treatment of cancer.  Immunotherapy encompasses a class of drugs called PD-1 and PD-L1 inhibitors and are marketed under the names Keytruda, Opdivo, Tecentriq, Durvalumab, Libtayo, among others. These drugs bind to receptors on T lymphocytes and cancer cells and block the ability of cancer cells to elude the immune system. Responses can be dramatic and last for years. Unfortunately, immunotherapy treatments only work 30 to 40% of the time.


Often cancer patients only have one chance for immunotherapy to work. What can be done to boost response rates?


Consider the following observations



Should all patients taking immunotherapy be encouraged to change their diet to incorporate more plant-based foods like fruits and vegetables? Should they all start taking probiotics? If this becomes the standard of care, remember you read about it here first!



References